Notice: Prescription Drug List (PDL): Multiple Additions (2021-07-23)
The purpose of this Notice of Amendment is to notify about the additions of the following medicinal ingredients on the Prescription Drug List (PDL) for human and veterinary use: Brexucabtagene autoleucel; Idecabtagene vicleucel; Pitolisant; Risdiplam; Selpercatinib; Solriamfetol; Tepotinib; Tildrakizumab; Trastuzumab; deruxtecan.
- Publisher - Current Organization Name: Health Canada
- Licence: Open Government Licence - Canada
Data and Resources
-
Notice: Prescription Drug List (PDL): Multiple Additions (2021-07-23)HTMLEnglish publication HTML
-
Notice: Prescription Drug List (PDL): Multiple Additions (2021-07-23)HTMLFrench publication HTML
Similar records